Infection Control Market

Steris plc (US), Getinge AB (Sweden), Cantel Medical Corporation (US) are the Leading Players in the Infection Control Market

The infection control market is projected to reach USD 52.7 billion by 2026 from USD 44.7 billion in 2021, at a CAGR of 3.4% during the forecast period. Growth in this market is majorly driven by the high incidence of hospital-acquired infections; the increasing number of surgical procedures; the growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. The growing number of medical device and pharmaceutical companies in emerging economies will also support the growth of the market in the coming years. Currently, with the surge in cases of COVID-19, there is an increasing focus on personal hygiene and increasing production of medical nonwovens and single-use products, such as face masks and gloves. This, in turn, is expected to propel market growth in the next two years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing, limited reimbursement in developing countries, and end-user non-compliance with sterilization standards, may hamper the growth of the market.

The global infection control market is fragmented and highly competitive, with various players governing major shares in the sterilization, disinfection, and endoscope reprocessing markets. Some of the major players governing the overall infection control market include Getinge AB (Sweden), STERIS plc. (US), Advanced Sterilization Products (US), Ecolab, Inc. (US), Cantel Medical Corporation (US), 3M Company (US), Belimed AG (Switzerland), Sotera Health LLC (US), Reckitt Benckiser Group Plc. (UK), MMM Group (Germany), MATACHANA GROUP (Spain), and Metrex Research Corporation (US). However, in the last few years, a number of smaller players have emerged from niche markets and are competing with global players based on price and technological innovation. Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired technological capabilities or geographic presence.

To know about the assumptions considered for the study download the pdf brochure

STERIS plc is a leading company in the infection control industry and is a leading provider of sterilization products and services. The company’s broad product portfolio is its key strength. STERIS markets an array of contract processing services using gamma irradiation, electron beam processing, and EtO technologies, along with a range of laboratory testing services. It also has a strong geographic presence across North America, Latin America, Europe, Asia, and the Middle East & Africa. The company derives most of its revenues from North America, specifically the US market. It dominates the sterilization products and services market and also has a significant position in the disinfectants market. To further expand and maintain its leading market position, STERIS focuses both on organic and inorganic strategies, such as product launches, acquisitions, and agreements. In 2020, it announced the addition of X-ray services to its facilities in Thailand, adding to its existing gamma irradiation capacity. STERIS also focuses on acquiring small to medium-sized players operating in the infection control market. It acquired Key Surgical (US) and Medisafe Group (UK) in the past few years to strengthen its presence in the global market.

Getinge AB holds a significant market position in both the sterilization products & services and disinfectants markets. Getinge has built an extensive product portfolio of infection control products. The company offers flusher disinfectors, washer-disinfectors, and cart washer-disinfectors in this market. It derives a majority of its revenue from the developed regions of North America and Europe. The US accounted for 33% of the Group’s sales and was the only country that accounted for more than 10% of total sales in 2020. The company has a diversified consumer base that includes hospitals, medical device & pharmaceutical companies, and universities. In June 2018, the company became one of the suppliers of Karolinska Institutet, a medical university in Sweden, having one of Europe’s largest laboratories. It focuses on organic and inorganic growth strategies, such as product launches, agreements, and acquisitions, which enable it to further strengthen its market position. In the last three years, Getinge has launched a number of products, such as steam sterilizers, washer-disinfectors, and biological indicators, in the market. These products offer procedure efficiency and low-processing time, aiding the overall sterilization or disinfection process.

Related Reports:

Infection Control Market by Product [Sterilization (Steam, Hydrogen Peroxide, EtO), Disinfection (Wipes, Liquids, Disinfectors), Services, E-beam, Face Masks], End User (Hospitals, Pharmaceutical Companies), COVID-19 Impact - Global Forecast to 2026

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Infection Control Market Size,  Share & Growth Report
Report Code
MD 3503
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2022 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status